NUTX
Income statement / Annual
Last year (2023), Nutex Health, Inc.'s total revenue was $247.65 M,
an increase of 12.93% from the previous year.
In 2023, Nutex Health, Inc.'s net income was -$45.79 M.
See Nutex Health, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2011
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2011 |
| Operating Revenue |
$247.65 M
|
$219.29 M
|
$331.53 M
|
$273.42 M
|
$97.06 M
|
$91,373.00
|
$53,647.00
|
$0.00
|
$0.00
|
$2.55 M
|
| Cost of Revenue |
$212.87 M |
$205.84 M |
$152.25 M |
$1.82 M |
$1.66 M |
$62,298.00 |
$564,367.00 |
$473.00 |
$662.00 |
$1.53 M |
| Gross Profit |
$34.77 M |
$13.45 M |
$179.28 M |
$271.60 M |
$95.40 M |
$29,075.00 |
-$510,720.00 |
-$473.00 |
-$662.00 |
$1.02 M |
| Gross Profit Ratio |
0.14 |
0.06 |
0.54 |
0.99 |
0.98 |
0.32 |
-9.52 |
0 |
0 |
0.4 |
| Research and Development
Expenses |
$0.00
|
$0.00
|
$285,880.00
|
$557,257.00
|
$768,103.00
|
$545,223.00
|
$25,645.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative
Expenses |
$36.07 M
|
$18.03 M
|
$5.46 M
|
$115.13 M
|
$59.87 M
|
$1.16 M
|
$1.81 M
|
$0.00
|
$0.00
|
$1.86 M
|
| Selling & Marketing
Expenses |
$2.84 M
|
$0.00
|
$24,449.00
|
$166,759.00
|
$577,739.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$36.07 M
|
$18.03 M
|
$5.46 M
|
$115.13 M
|
$59.87 M
|
$1.16 M
|
$1.81 M
|
$448,122.00
|
$532,326.00
|
$1.86 M
|
| Other Expenses |
-$399,182.00 |
-$559,299.00 |
$5.42 M |
$5.96 M |
$2.48 M |
$633,572.00 |
$3.87 M |
$0.00 |
$0.00 |
$0.00 |
| Operating Expenses |
$36.07 M |
$18.03 M |
$5.46 M |
$121.09 M |
$62.35 M |
$1.80 M |
$5.69 M |
$448,122.00 |
$532,326.00 |
$1.86 M |
| Cost And Expenses |
$248.94 M |
$223.87 M |
$157.71 M |
$121.09 M |
$62.35 M |
$1.86 M |
$5.69 M |
$448,595.00 |
$532,988.00 |
$3.39 M |
| Interest Income |
$0.00 |
$12.49 M |
$917.00 |
$1,030.00 |
$3,626.00 |
$0.00 |
$0.00 |
$114.00 |
$4.00 |
$29,139.00 |
| Interest Expense |
$16.32 M |
$12.49 M |
$6.20 M |
$6.43 M |
$3.53 M |
-$642,070.00 |
-$367,352.00 |
$2,579.00 |
$3,146.00 |
$0.00 |
| Depreciation &
Amortization |
$17.59 M
|
$13.20 M
|
$7.76 M
|
$236,546.00
|
$179,469.00
|
$522.00
|
$535,024.00
|
$473.00
|
$662.00
|
$0.00
|
| EBITDA |
$16.30 M
|
$7.99 M
|
$186.90 M
|
$157.95 M
|
$38.10 M
|
-$1.83 M
|
-$5.69 M
|
-$448,130.00
|
-$532,330.00
|
-$844,577.00
|
| EBITDA Ratio |
0.07 |
0.04 |
0.56 |
0.58 |
0.39 |
-20.03 |
-106.12 |
0 |
0 |
-0.33 |
| Operating Income Ratio
|
-0.01
|
-0.02
|
0.51
|
0.56
|
0.36
|
-20.03
|
-106.12
|
0
|
0
|
-0.33
|
| Total Other
Income/Expenses Net |
-$47.20 M
|
-$414.51 M
|
-$773,882.00
|
-$6.78 M
|
-$2.62 M
|
-$983,684.00
|
$6.27 M
|
-$2,460.00
|
-$3,140.00
|
$29,139.00
|
| Income Before Tax |
-$48.49 M |
-$419.65 M |
$169.49 M |
$145.56 M |
$32.09 M |
-$2.81 M |
$582,062.00 |
-$451,060.00 |
-$536,130.00 |
-$815,438.00 |
| Income Before Tax Ratio
|
-0.2
|
-1.91
|
0.51
|
0.53
|
0.33
|
-30.8
|
10.85
|
0
|
0
|
-0.32
|
| Income Tax Expense |
-$5.07 M |
$13.09 M |
$965,731.00 |
$50.83 M |
$15.61 M |
-$161,141.00 |
-$535,024.00 |
$6.98 M |
-$619,941.00 |
-$432,045.00 |
| Net Income |
-$45.79 M |
-$432.74 M |
$132.59 M |
$105.97 M |
$16.48 M |
-$2.81 M |
$582,062.00 |
-$7.43 M |
$83,809.00 |
-$383,393.00 |
| Net Income Ratio |
-0.18 |
-1.97 |
0.4 |
0.39 |
0.17 |
-30.8 |
10.85 |
0 |
0 |
-0.15 |
| EPS |
-1.05 |
-10.24 |
3.36 |
2.68 |
0.4 |
-0.0392 |
0.0139 |
-14045.09 |
1.44 |
-0.032 |
| EPS Diluted |
-1.04 |
-10.22 |
3.3 |
2.68 |
0.4 |
-0.0392 |
0.0139 |
-14045.09 |
1.44 |
-0.032 |
| Weighted Average Shares
Out |
$43.61 M
|
$42.27 M
|
$40.18 M
|
$42.92 M
|
$41.40 M
|
$71.84 M
|
$41.84 M
|
$529.17
|
$58,336.00
|
$11.98 M
|
| Weighted Average Shares
Out Diluted |
$44.08 M
|
$42.33 M
|
$39.52 M
|
$42.92 M
|
$41.40 M
|
$71.84 M
|
$41.84 M
|
$529.17
|
$58,336.00
|
$11.98 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
